Atossa Therapeutics
ATOS
ATOS
45 hedge funds and large institutions have $11.9M invested in Atossa Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 8 closing their positions.
Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
17
Closed
8
Calls
$779K
Puts
$64K
Net Calls
+$715K
Net Calls Change
-$78K
Top Buyers
Top Sellers
| 1 |
1
D.E. Shaw & Co
New York
|
$597K |
| 2 |
2
BlackRock
New York
|
$2.32M |
| 3 |
3
Bank of Montreal
Toronto,
Ontario, Canada
|
$0 |
| 4 |
SM
4
Sabby Management
Miami Beach,
Florida
|
$47.6K |
| 5 |
5
Millennium Management
New York
|
$336K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
51
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
HFS
52
Hantz Financial Services
Southfield,
Michigan
| $0 | 82 | – | – |
|
|
HT
53
HAP Trading
New York
| – | – | – | – |
|
54
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CM
55
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
56
JPMorgan Chase & Co
New York
| $0 | 94 | – | – |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 20 | +20 | New |
|